Stay up to date at MIMS Learning with our expert advisers
It’s not too late to book your free place at MIMS Learning Live on Friday 10 June in London. Gain 5.5 CPD hours of learning […]
It’s not too late to book your free place at MIMS Learning Live on Friday 10 June in London. Gain 5.5 CPD hours of learning […]
It’s not too late to book your free place at MIMS Learning Live on Friday 10 June in London. Gain 5.5 CPD hours of learning […]
Welcome to the 3rd Annual RNAi – Based Therapeutics Summit: Overcoming Barriers for Targeted siRNA Therapeutics Built with biopharmaceutical industry insights, this in person conference will bring […]
Turbocharge the Development of the Best-In-Class Kinase Inhibitor Products, to Enhance Specificity, Overcome Resistance to Deliver Safe & Durable Clinical Responses Celebrating 20 years of […]
Shots: The non-IND/CTA study evaluates KB295 in patients with UC. The study evaluates other exploratory assessments including changes in microbiome composition, SCFA levels & biomarkers […]
Called RecoverX, the company will leverage AI to mine evidence-based research, medical charts, patient conversations and test results and provide clinical insights for clinicians in […]
Health IT company Apervita will leverage Diameter Health’s capabilities — which include cleaning and enriching clinical data — to enhance data quality for stakeholders looking […]
Clinical 2021 is US and EU pharma’s leading event for clinical innovators – join 500+ executive attendees from across the globe to meet and learn […]
CIOs need to look beyond just EHRs and explore standalone platforms to enhance care delivery – keeping focused on reliable patient data and streamlined clinical […]
Shots: The company reported that the COVID-19 vaccine is safe, well-tolerated & immunogenic in the P-I/II study & plans to initiate P-III clinical trial in […]
Shots: The P-I clinical trial involves assessing CT-P59 (20/40/80 mg/kg) vs PBO in 18 patients with mild symptoms of SARS-COV-2 infection who were randomized into […]
Shots: The 7 studies include one Proffered Paper Oral Presentation & 6 e-posters, covering indications including lung cancer, liver cancer, gastric cancer, & esophageal cancer […]
Shots: The P-II trial will assess BI 764198 (qd for ~4wks.) in patients hospitalized for COVID-19 with expected enrollment initiation in Oct’2020. The 1EPs will […]
Shots: The company has expanded its Direct-to-Patient service offerings for supporting decentralized clinical trials to lessen clinical trial lengths and costs while increasing patient enrollment […]
Shots: GSK reported that its RSV vaccines for maternal immunization (GSK3888550A) and older adults (GSK3844766A) were well-tolerated and highly immunogenic in P-I/II clinical studies. Both […]
Shots: The companies will advance the prasinezumab into a P-IIb study in patients with early Parkinson’s disease based on positive signals of efficacy consistent with […]
Shots: The independent DSMB recommended pausing the enrollment of the ACTIV-3 clinical trial. The trial is evaluating Lilly’s bamlanivimab (LY-CoV555, 7000mg) + remdesivir as a […]
PRISYM ID appoints Software Delivery Manager to oversee team developing new clinical labeling solutions Wokingham, United Kingdom — 30 September 2020 — PRISYM ID, a leading provider of regulated content and label management solutions, has announced […]
The clinical manifestations of COVID-19 are varied, and patients are known to have rapidly changing signs and symptoms that must be tracked with laboratory testing. […]
CMS requirements for approved clinical decision support mechanisms could cause extra burden and more keystrokes for physicians attempting to meet appropriate use criteria.
Copyright © 2024 | WordPress Theme by MH Themes